Search research articles
Contact Us
Filters
Showing results (71-80 of 144) with videos related to
Page
of 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers
A Ihbe-Heffinger, B Ehlken, R Bernard, et al.
Abdominal Imaging
|
September 10, 2004
PET/CT molecular imaging in abdominal oncology
A Stahl, H Wieder, H J Wester, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
SAGA-a phase Ib/II single-arm, multicenter study of sacituzumab govitecan for patients with metastatic esophagogastric adenocarcinoma
B Kobitzsch, G Stocker, U T Hacker, et al.
Nuklearmedizin. Nuclear Medicine
|
December 18, 2007
Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET
S Lorenzen, K Herrmann, W A Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 2, 2010
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study
M Moehler, A Mueller, T Trarbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2008
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group
D Arnold, T Höhler, C Dittrich, et al.
Journal of Cancer Research and Clinical Oncology
|
December 13, 2022
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study
B Jansen-Winkeln, J Eberth, Y Moulla, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
March 22, 2012
[S3 guideline - diagnosis and treatment of gastric carcinoma: relevance for radiologic imaging]
L Grenacher, M Schwarz, F Lordick, et al.
ESMO Open
|
February 25, 2026
Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies
K Shitara, E Smyth, F Lordick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 2022
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
R Obermannová, M Alsina, A Cervantes, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 144) with videos related to
Sort By:
Page
of 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers
A Ihbe-Heffinger, B Ehlken, R Bernard, et al.
Abdominal Imaging
|
September 10, 2004
PET/CT molecular imaging in abdominal oncology
A Stahl, H Wieder, H J Wester, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
SAGA-a phase Ib/II single-arm, multicenter study of sacituzumab govitecan for patients with metastatic esophagogastric adenocarcinoma
B Kobitzsch, G Stocker, U T Hacker, et al.
Nuklearmedizin. Nuclear Medicine
|
December 18, 2007
Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET
S Lorenzen, K Herrmann, W A Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 2, 2010
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study
M Moehler, A Mueller, T Trarbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2008
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group
D Arnold, T Höhler, C Dittrich, et al.
Journal of Cancer Research and Clinical Oncology
|
December 13, 2022
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study
B Jansen-Winkeln, J Eberth, Y Moulla, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
March 22, 2012
[S3 guideline - diagnosis and treatment of gastric carcinoma: relevance for radiologic imaging]
L Grenacher, M Schwarz, F Lordick, et al.
ESMO Open
|
February 25, 2026
Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies
K Shitara, E Smyth, F Lordick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 2022
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
R Obermannová, M Alsina, A Cervantes, et al.
Page
of 15